<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34188995</PMID><DateRevised><Year>2021</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>May</Month><Day>26</Day></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Functional and Radiological Improvement in a COVID-19 Pneumonia Patient Treated With Steroids.</ArticleTitle><Pagination><StartPage>e15257</StartPage><MedlinePgn>e15257</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e15257</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.15257</ELocationID><Abstract><AbstractText>Like its predecessors, coronavirus disease 2019 (COVID-19) can lead to&#xa0;long-term health-related consequences in a significant segment of the afflicted population. Although the medical community has developed multiple vaccines by now, COVID-19 has affected over 100 million individuals worldwide and will infect millions more before&#xa0;vaccines can be effectively distributed on a global scale. Additionally, it seems probable that another outbreak caused by a coronavirus may occur in the future, given that this is the third outbreak caused by a coronavirus in recent history. In light of this, the medical community must develop reliable methods of curtailing long-term sequelae of coronaviruses, and the use of corticosteroids in affected patients may be vital for this purpose. In this report, we present a case of progressive dyspnea caused by COVID-19 pneumonia; the patient was treated with a short course of oral corticosteroids, and subsequently showed marked improvement of the dyspnea with corresponding improvements on chest CT.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021, Singh et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Rahul</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Accident and Emergency, Dr. Balwant Singh's Hospital, Georgetown, GUY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaziano</LastName><ForeName>Dominic</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Family Medicine, Amita Health, Chicago, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute respiratory distress syndrome [ards]</Keyword><Keyword MajorTopicYN="N">ards (acute respiratory distress syndrome)</Keyword><Keyword MajorTopicYN="N">corona virus disease 2019</Keyword><Keyword MajorTopicYN="N">corticosteroid medication</Keyword><Keyword MajorTopicYN="N">covid</Keyword><Keyword MajorTopicYN="N">covid induced ards</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">sars-cov-2 induced ards</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>5</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34188995</ArticleId><ArticleId IdType="pmc">PMC8231732</ArticleId><ArticleId IdType="doi">10.7759/cureus.15257</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Persistent symptoms in patients after acute COVID-19. Carf&#xec; A, Bernabei R, Landi F. JAMA. 2020;324:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Hui DS, Wong KT, Ko FW, Tam LS, Chan DP, Woo J, Sung JJ. Chest. 2005;128:2247&#x2013;2261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094276</ArticleId><ArticleId IdType="pubmed">16236881</ArticleId></ArticleIdList></Reference><Reference><Citation>Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Zhang P, Li J, Liu H, et al. Bone Res. 2020;8:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7018717</ArticleId><ArticleId IdType="pubmed">32128276</ArticleId></ArticleIdList></Reference><Reference><Citation>The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Ngai JC, Ko FW, Ng SS, To KW, Tong M, Hui DS. Respirology. 2010;15:543&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7192220</ArticleId><ArticleId IdType="pubmed">20337995</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Bernheim A, Mei X, Huang M, et al. Radiology. 2020;295:200463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233369</ArticleId><ArticleId IdType="pubmed">32077789</ArticleId></ArticleIdList></Reference><Reference><Citation>Dexamethasone in hospitalized patients with Covid-19. Horby P, Lim WS, Emberson JR, et al. N Engl J Med. 2021;384:693&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Quality of life, pulmonary function, and tomographic scan abnormalities after ARDS. Masclans JR, Roca O, Mu&#xf1;oz X, Pallisa E, Torres F, Rello J, Morell F. Chest. 2011;139:1340&#x2013;1346.</Citation><ArticleIdList><ArticleId IdType="pubmed">21330382</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019 (Article in Chinese) Zhang T, Sun LX, Feng RE. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:496&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">32241072</ArticleId></ArticleIdList></Reference><Reference><Citation>An inflammatory cytokine signature predicts COVID-19 severity and survival. Del Valle DM, Kim-Schulze S, Huang HH, et al. Nat Med. 2020;26:1636&#x2013;1643.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>The fibroproliferative phase of late adult respiratory distress syndrome. Meduri GU, Eltorky M, Winer-Muram HT. https://pubmed.ncbi.nlm.nih.gov/7481129/ Semin Respir Infect. 1995;10:154&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">7481129</ArticleId></ArticleIdList></Reference><Reference><Citation>Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome. Meduri GU, Chinn AJ, Leeper KV, et al. Chest. 1994;105:1516&#x2013;1527.</Citation><ArticleIdList><ArticleId IdType="pubmed">8181346</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozone-induced acute pulmonary fibrosis in rats. Prevention of increased rates of collagen synthesis by methylprednisolone. Hesterberg TW, Last JA. Am Rev Respir Dis. 1981;123:47&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">7458086</ArticleId></ArticleIdList></Reference><Reference><Citation>Methylprednisolone as adjunctive therapy for patients hospitalized with coronavirus disease 2019 (COVID-19; Metcovid): a randomized, double-blind, phase iib, placebo-controlled trial. Jeronimo CMP, Farias MEL, Val FFA, et al. Clin Infect Dis. 2021;72:0&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454320</ArticleId><ArticleId IdType="pubmed">32785710</ArticleId></ArticleIdList></Reference><Reference><Citation>Late worsening of COVID-19 pneumonia: successful treatment with ruxolitinib and steroid. Betelli M, De Stefano F, Tedeschi A. Eur J Case Rep Intern Med. 2020;7:1938.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7655002</ArticleId><ArticleId IdType="pubmed">33194871</ArticleId></ArticleIdList></Reference><Reference><Citation>Rapid radiological worsening and cytokine storm syndrome in COVID-19 pneumonia. Ruch Y, Kaeuffer C, Guffroy A, Lefebvre N, Hansmann Y, Danion F. Eur J Case Rep Intern Med. 2020;7:1822.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7350974</ArticleId><ArticleId IdType="pubmed">32665942</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus disease 2019-associated rapidly progressive organizing pneumonia with fibrotic feature: two case reports. Okamori S, Lee H, Kondo Y, et al. Medicine (Baltimore) 2020;99:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7458222</ArticleId><ArticleId IdType="pubmed">32871900</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>